Welcome to our dedicated page for International Flavors & Fragrances news (Ticker: IFF), a resource for investors and traders seeking the latest updates and insights on International Flavors & Fragrances stock.
International Flavors & Fragrances Inc. (IFF) is a leading innovator in creating sensorial experiences that drive the world of flavors and fragrances. Headquartered in New York, the company partners with customers globally to develop unique products for the food, beverage, health, personal care, and household goods industries. With a strong commitment to discovery and innovation, IFF continuously explores new possibilities in both fine fragrances and beauty, as well as in beloved foods and beverages.
IFF's core businesses include the Nourish segment, which accounts for nearly half of its revenue. This segment specializes in producing flavors, texturants, and plant-based proteins, providing essential ingredients that enhance the appeal and functionality of food products. Additionally, the Health & Biosciences division, generating roughly one-fourth of the company's revenue, is renowned for its expertise in probiotics and enzymes, making significant contributions to health and wellness solutions.
The company leverages its global team of 7,300 professionals along with leading consumer insights, research and development, and creative expertise to deliver differentiated products. Their proprietary formulations and custom solutions are a testament to their innovative approach and customer-centric focus.
IFF has recently made remarkable advancements in excipient technology, presenting its comprehensive range at global events such as CPhI Japan 2024 and Vitafoods Europe 2024. These showcases highlight the company's commitment to driving pharmaceutical innovation, with notable products like METHOCEL™, ETHOCEL™, and POLYOX™ under its new controlled release platform, 'Timing is Everything'. This new platform emphasizes the importance of controlled release in pharmaceutical therapies, aiming to improve patient compliance and treatment efficacy.
IFF continues to expand its innovative offerings and partnerships, demonstrating a significant impact across various industries. The company's dedication to sustainability and precision in science and creativity positions it as a key player in transforming everyday experiences and contributing to a better world.
For more detailed information about their latest projects and developments, visit their official website at iff.com.
IFF (NYSE: IFF) announced research with UCAM showing that its AB-Fortis® iron ingredient is better tolerated than traditional iron salts. The microencapsulated iron, derived from natural alginate, minimizes gastrointestinal discomfort and enhances absorption. This technology addresses common issues faced by users of iron supplements, especially vegetarians and vegans. A clinical study indicates significant tolerability advantages over ferrous sulfate, with fewer side effects. The ingredient's high iron content allows small dosages without affecting taste.
IFF has appointed Dennis Maroney as Master Perfumer, recognizing his 32-year career and significant contributions to the global perfumery industry. Maroney, IFF's ninth Master Perfumer, is acknowledged for his exceptional leadership and influence. Ceo Frank Clyburn highlighted Maroney's unique ability to merge science and creativity, creating iconic fragrances across beauty and home care products. His background includes roles at Kato and IFF’s predecessor. Maroney has won multiple Perfumer Choice Awards and served in leadership roles in industry organizations, further underscoring his impact in perfumery.
IFF (NYSE: IFF) has announced its 2022 Investor Day presentation, scheduled for Wednesday, Dec. 7, 2022, at 1:00 p.m. ET. Investors can access the live webcast and slide presentation through the company's website at ir.iff.com. A recorded version will also be available for those unable to attend live. IFF is a leader in food, beverage, health, biosciences, and scent, combining science and creativity to deliver essential solutions.
IFF has announced a strategic partnership with Salus Optima to enter the personalized nutrition sector, targeting metabolic health issues affecting over 25% of adults globally. The collaboration aims to offer brand owners a digital platform populated with health-focused products while leveraging IFF's health-enabling ingredients. The platform will provide real-time consumer data and personalized suggestions via mobile and wearables, enhancing consumer engagement and brand value.
IFF reported Q3 2022 results, revealing consolidated sales of $3.06 billion, flat year-over-year. A significant goodwill impairment charge of $2.25 billion was recorded due to increased interest rates and lower business projections. Adjusted EBITDA reached $612 million, with an operating margin of 20%. EPS was reported at $(8.60), while adjusted EPS was $1.36. The company revised its full-year sales guidance to $12.4-$12.5 billion, down from $12.6-$13.0 billion, citing adverse foreign exchange impacts. Nonetheless, the firm anticipates a 9-10% growth in comparable currency neutral sales.
IFF has launched its innovative plant-based protein, SUPRO® TEX, aimed at enhancing the meat alternative market. This product mimics the texture of whole muscle meat with 80% soy protein and offers ease of production without significant capital investment or refrigerated supply chains. Market researchers predict a shift towards plant-based proteins, with consumer demand driven by health and ethical concerns. SUPRO® TEX enables manufacturers to create various meat-like textures and flavors, catering to a growing market interest in sustainable food options.
IFF (NYSE: IFF) will release its third quarter 2022 earnings results after market close on November 7, 2022. Following this, a live webcast is scheduled for November 8, 2022, at 9:00 a.m. ET, where the management team will discuss the results and future outlook with investors. Access to the webcast and related presentation will be available on the Company's website at ir.iff.com. IFF is a leader in food, beverage, health, biosciences, and scent.
IFF has appointed Ralf Finzel as the new executive vice president and global operations officer, effective November 1, 2022. Finzel, a seasoned operations executive with over 30 years of experience, previously served as vice president of Integrated Supply Chain at Honeywell. He has a strong background in operations and supply chain management and holds multiple academic degrees in Chemistry. The change follows the departure of Francisco Fortanet, who exits after a transition period. CEO Frank Clyburn expresses confidence in Finzel's ability to drive IFF's success.
FAQ
What is the current stock price of International Flavors & Fragrances (IFF)?
What is the market cap of International Flavors & Fragrances (IFF)?
What does International Flavors & Fragrances Inc. (IFF) do?
What are the core business segments of IFF?
Where is IFF headquartered?
How many employees does IFF have?
What are some recent innovations by IFF?
What is the significance of the 'Timing is Everything' platform?
How does IFF support the food industry?
What role does IFF play in the health sector?
Where can I find more information about IFF's products and services?